Wegovy Archives -

Wegovy

Denmark’s Novo Nordisk has been almost single-handedly rebuilding the market for drugs to treat obesity over the last

Lilly fires a broadside at Novo Nordisk’s obesity ambitions

https://pharmaphorum.com/news/lilly-fires-a-broadside-at-novo-nordisks-obesity-ambitions/

Novo Nordisk’s rollout of obesity therapy Wegovy has been beset by production problems, but the company says these

Novo Nordisk eyes obesity sales of $3.7bn in 2025 thanks to Wegovy

https://pharmaphorum.com/news/novo-nordisk-eyes-obesity-sales-of-3-7bn-in-2025-thanks-to-wegovy/

Novo Nordisk’s new obesity therapy Wegovy has been recommended for routine NHS use by UK cost-effectiveness watchdog NICE,

Novo Nordisk gets NICE okay for obesity drug Wegovy

https://pharmaphorum.com/news/novo-nordisk-gets-nice-okay-for-obesity-drug-wegovy/

Danish drugmaker Novo Nordisk is hoping to launch its once-weekly injectable treatment for obesity, Wegovy, in the EU

Novo Nordisk nears EU approval of obesity drug Wegovy

https://pharmaphorum.com/news/novo-nordisk-nears-eu-approval-of-obesity-drug-wegovy/

Novo Nordisk is celebrating the FDA approval of its GLP-1 agonist semaglutide as a treatment for obesity, which

FDA ends 7-year obesity drug drought, clearing Novo Nordisk’s Wegovy

https://pharmaphorum.com/news/fda-ends-obesity-drug-drought/

Wegovy